Join
Live feed
·
INSIDERFilingvia Quantisnow
Aardvark Therapeutics Inc. logo

Chief Financial Officer Sun Nelson converted options into 7,001 shares and bought $160,000 worth of shares (10,000 units at $16.00), increasing direct ownership by 21% to 99,484 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AARD (Aardvark Therapeutics Inc.) and more on Quantisnow.